Activity value 92united states Buyer&Supplier,Last transaction date:
2026-02-05Address: 87 modular ave commack ny 11725 united states
Overview
Contact
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for gemini pharmaceuticals from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 1 transactions, with a transaction quantity of 37 and a transaction weight of 3995.
YearTransactionsQuantityWeight
20251356433029
20261373995
Bill of lading data
<
1/15
>
Trade date
2026/02/05
B/L No.
zhjlnbf25121394
Suppliers
mass enterprise pte. ltd.
Buyers
gemini pharmaceuticals
POLs
57020, ningpo
PODs
4601, new york/newark area, newark, nj
gemini pharmaceuticals is united states Buyer&Supplier,
and primarily engages in the import and export business of products such as plastic bottles,plastic cap,caps.
According to the 52wmb.com global trade database, as of 2026-02-05, the company has completed 563 international trades,
with its main trading regions covering india,china,hong kong etc.
The core products include HS13021919,HS84229090,HS30024910 etc,
often transported via new york,port newark nj, port farmingdale etc,
and its main trading partners are acg pam pharma technologies pvt ltd.,cmc machinery international,acg pam pac machines pvt ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on gemini pharmaceuticals is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.